BSECompany Update16 Sept 2026 · 16 Sept 2026, 05:51 pm

Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the Company has filed two complaints on September 15,2026 against M/s Anugraha Chemicals ("the Firm") and its partners, on account of dishonour of two cheques issued by the firm towards discharge of outstanding dues payable to the Company.

Pharmaids Pharmaceuticals Ltd · 524572

✦ AI SummaryLitigation

Pharmaids Pharmaceuticals Ltd has filed two complaints against M/s Anugraha Chemicals and its partners for dishonour of two cheques worth ₹2,62,50,000, payable to the Company. The Company is seeking recovery of the outstanding amount.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Pharmaids Pharmaceuticals Ltd - 524572 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

fdcdf501-af4d-4255-8ed7-10785490a295.pdf

pdf

Download →
View document text
Date: 16.09.2026 BSE Limited Corporate Relations Department Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001 Dear Sir/Madam, Scrip Code: 524572 | Scrip ID: PHARMAID | ISIN: INE117D01018 Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), as amended thereof, we hereby inform that the Company has filed two complaints under Section 223 of the Bharatiya Nagarik Suraksha Sanhita, 2023 read with Section 138 of the Negotiable Instruments Act, 1881 on September 15, 2026, against M/s Anugraha Chemicals ("the Firm") and its partners, on account of dishonour of two cheques issued by the firm towards discharge of outstanding dues payable to the Company. The details required to be disclosed as provided in Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are set out in Annexure 1. Kindly take the same on your record and oblige. For Pharmaids Pharmaceuticals Limited Prasanna Subramanya Bhat (Company Secretary & Compliance Officer) PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com Annexure 1 DETAILS WHICH A LISTED ENTITY NEED TO DISCLOSE FOR EVENTS ON WHICH THE LISTED ENTITY SHALL APPLY MATERIALITY IN TERMS OF PARA B OF PART A OF SCHEDULE III OF THE LODR REGULATIONS. Details of the event Information of such event 1. Brief details of litigation Name(s) of the opposing party 1. M/s Anugraha Chemicals (the “firm”) 2. Mr. Sourabh S. Hadimani (partner) 3. Mrs. Sneha Hadimani (partner) Court/Tribunal/Agency where litigation Hon’ble Court of the 34th Additional Chief is filed Judicial Magistrate, Bengaluru Brief details of dispute/litigation The Company has filed two complaints under Section 223 of the Bharatiya Nagarik Suraksha Sanhita, 2023 read with Section 138 of the Negotiable Instruments Act, 1881 on September 15, 2026, against Anugraha Chemicals and its partners for dishonour of two cheques (Cheque Nos. 740165 and 740166) issued towards discharge of an outstanding amount of ₹2,62,50,000/- (Rupees Two Crore Sixty-Two Lakh Fifty Thousand only), payable to the Company pursuant to a Disinvestment Agreement dated 10.07.2025 (as modified by a Supplementary Agreement dated 23.01.2026), executed in connection with the Company's exit from its partnership interest in Anugraha Chemicals. Both cheques were dishonoured on 23.07.2026 with the remark "Payment Stopped by the Drawer," and despite issuance of statutory demand notices, the outstanding amount remains unpaid. 2. Expected financial implications, if any, There are no financial implications or due to compensation, penalty etc liabilities on the Company arising from this litigation, as the Company is the Complainant seeking recovery of amounts due to it. PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com 3. Quantum of claims, if any The aggregate quantum of claim is ₹2,62,50,000/- (Rupees Two Crore Sixty- Two Lakh Fifty Thousand only), being the outstanding amount covered under the two dishonoured cheques (₹52,50,000/- under Cheque No. 740165 and ₹2,10,00,000/- under Cheque No. 740166), exclusive of any compensation, interest, or costs that may be awarded by the Court. PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com